J.J. Thebault

653 total citations
22 papers, 542 citations indexed

About

J.J. Thebault is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, J.J. Thebault has authored 22 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Molecular Biology. Recurrent topics in J.J. Thebault's work include Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Estrogen and related hormone effects (3 papers) and Menopause: Health Impacts and Treatments (3 papers). J.J. Thebault is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Estrogen and related hormone effects (3 papers) and Menopause: Health Impacts and Treatments (3 papers). J.J. Thebault collaborates with scholars based in France, Canada and Germany. J.J. Thebault's co-authors include Armand Frydman, Henri Caplain, Y. Le Roux, J. Bouthier, E Panak, J Blanchard, F. Collignon, J. Gaillot, René Bruno and A. Le Liboux and has published in prestigious journals such as The American Journal of Cardiology, European Journal of Pharmacology and Clinical Pharmacology & Therapeutics.

In The Last Decade

J.J. Thebault

21 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.J. Thebault France 11 211 141 123 91 62 22 542
P.R. Emmons Canada 9 279 1.3× 79 0.6× 102 0.8× 104 1.1× 29 0.5× 10 618
Silvia Villa Italy 12 174 0.8× 50 0.4× 66 0.5× 100 1.1× 20 0.3× 26 546
Erik Myhre Norway 16 471 2.2× 126 0.9× 209 1.7× 80 0.9× 35 0.6× 47 950
R Richter Germany 8 368 1.7× 80 0.6× 163 1.3× 134 1.5× 14 0.2× 23 564
P Leiberman United Kingdom 8 77 0.4× 38 0.3× 135 1.1× 93 1.0× 129 2.1× 10 445
Henri Caplain France 12 287 1.4× 244 1.7× 206 1.7× 30 0.3× 44 0.7× 23 619
David R. Lowry United States 12 531 2.5× 97 0.7× 242 2.0× 60 0.7× 17 0.3× 17 671
A. G. G. Turpie Canada 15 575 2.7× 516 3.7× 213 1.7× 48 0.5× 23 0.4× 41 956
James F. Mustard Canada 5 186 0.9× 68 0.5× 73 0.6× 86 0.9× 8 0.1× 6 465
Min Fu United States 14 369 1.7× 87 0.6× 73 0.6× 25 0.3× 56 0.9× 32 799

Countries citing papers authored by J.J. Thebault

Since Specialization
Citations

This map shows the geographic impact of J.J. Thebault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.J. Thebault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.J. Thebault more than expected).

Fields of papers citing papers by J.J. Thebault

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.J. Thebault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.J. Thebault. The network helps show where J.J. Thebault may publish in the future.

Co-authorship network of co-authors of J.J. Thebault

This figure shows the co-authorship network connecting the top 25 collaborators of J.J. Thebault. A scholar is included among the top collaborators of J.J. Thebault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.J. Thebault. J.J. Thebault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gillotin, Catherine, et al.. (1997). Lack of Interaction Between Oral Dihydroergotamine and the Novel Antimigraine Compound Zolmitriptan in Healthy Volunteers. Clinical Drug Investigation. 14(3). 217–220. 10 indexed citations
3.
Birkhäuser, Martin, R Lambotte, Bruno Pornel, et al.. (1996). Comparison of two estradiol transdermal systems (Oesclim® 50 and estraderm TTS® 50). II. Local skin tolerability. Maturitas. 25(3). 175–185. 20 indexed citations
4.
Rosenzweig, P., et al.. (1995). Comparative wheal and flare study of mizolastine vs terfenadine, cetirizine, loratadine and placebo in healthy volunteers.. PubMed Central. 40(5). 459–65. 34 indexed citations
5.
Roux, Y. Le, et al.. (1995). Bioavailability Study of Menorest®, a New Estrogen Transdermal Delivery System, Compared with a Transdermal Reservoir System. Clinical Drug Investigation. 10(3). 172–178. 21 indexed citations
6.
7.
Montay, Guy, René Bruno, J. Vergniol, et al.. (1994). Pharmacokinetics of Sparfloxacin in Humans After Single Oral Administration at Doses of 200, 400, 600, and 800 mg. The Journal of Clinical Pharmacology. 34(11). 1071–1076. 34 indexed citations
8.
Chassard, D, et al.. (1994). [Gastroduodenal tolerance of methylprednisolone. Study of oral versus intravenous administration in healthy volunteers].. PubMed. 23(11). 515–7. 1 indexed citations
9.
Leroy, Pierre, et al.. (1992). The pharmacokinetics of tiopronin and its principal metabolite (2-mercaptopropionic acid) after oral administration to healthy volunteers. European Journal of Clinical Pharmacology. 43(1). 93–95. 14 indexed citations
10.
Collignon, F., Bernadette Darné, Henri Caplain, et al.. (1992). Pharmacokinetics of enoxaparin in man given single subcutaneous doses of 1.0-1.25–1.50-2.0 mg/kg. Thrombosis Research. 65. S167–S167. 1 indexed citations
11.
Dahan, R, et al.. (1991). A single blind normal volunteer bioavailability study of a new microencapsulated potassium chloride tablet compared with two reference potassium formulations. European Journal of Drug Metabolism and Pharmacokinetics. 16(3). 241–244. 5 indexed citations
12.
Montay, Guy, Y. Le Roux, A. Le Liboux, et al.. (1991). Comparative Bioavailability Study of Cefixime Administered as Tablets or Aqueous Solution. Drugs. 42(Supplement 4). 6–9. 11 indexed citations
13.
Rosenzweig, P., J.J. Thebault, Henri Caplain, & P.L. Morselli. (1990). SL 85.0324: a new non sedative H1 antagonist drug. European Journal of Pharmacology. 183(2). 533–534. 2 indexed citations
14.
Montay, Guy, et al.. (1989). [Pharmacokinetics of cefixime in healthy volunteers after a single oral administration of 200 mg].. PubMed. 18(32). 1583–6. 6 indexed citations
15.
Frydman, Armand, H. W. Diekmann, René Bruno, et al.. (1989). Pharmacokinetics of nicorandil. The American Journal of Cardiology. 63(21). J25–J33. 71 indexed citations
16.
Thebault, J.J., et al.. (1987). The Influence of Food on the Bioavailability of a Slow Release Theophylline Preparation. Clinical Pharmacokinetics. 13(4). 267–272. 9 indexed citations
17.
Taburet, A M, et al.. (1986). Pharmacokinetics of ornidazole in patients with severe liver cirrhosis. Clinical Pharmacology & Therapeutics. 40(3). 359–364. 7 indexed citations
18.
Hirtz, J, et al.. (1979). Clinical pharmacology studies with acenocoumarol.. PubMed. 17(8). 361–5. 1 indexed citations
19.
Thebault, J.J., et al.. (1977). Clinical pharmacology of flurbiprofen: a novel inhibitor of platelet aggregation. Current Medical Research and Opinion. 5(1). 130–134. 8 indexed citations
20.
Aubert, D., et al.. (1975). In Vivo Activity of Tieclopidine, a New Drug with Platelet Aggregation Inhibiting, Antisludge and Antithrombotic Properties. Thrombosis and Haemostasis. 34(1). 342–342. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P.R. Emmons Breakdown of academic impact, for papers by Silvia Villa Breakdown of academic impact, for papers by Erik Myhre Breakdown of academic impact, for papers by R Richter Breakdown of academic impact, for papers by P Leiberman Breakdown of academic impact, for papers by Henri Caplain Breakdown of academic impact, for papers by David R. Lowry Breakdown of academic impact, for papers by A. G. G. Turpie Breakdown of academic impact, for papers by James F. Mustard Breakdown of academic impact, for papers by Min Fu
Rankless by CCL
2026